Clinical Trial Update: Oropharyngeal Administration of Colostrum to Extremely Low Gestational Age Newborns [Phase 2]

View source ↗

Summary

Phase 2 trial sponsored by Seoul National University Hospital evaluating oropharyngeal administration of colostrum in extremely preterm infants; results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prematurity

Drugs mentioned

• colostrum (colostrum)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Extremely Low Gestational Age Newborn, Premature Infant | Phase 2 | Status: COMPLETED | Results posted: 2014-08-12